MeSH D001416 - back pain
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Teva | Naproxen | Naproxen |  | 1995-02-28 |  |  |
| Glenmark Pharmaceuticals | Naproxen | Naproxen |  | 2007-03-28 |  |  |
| Mylan | Naproxen | Naproxen |  | 1993-12-21 |  |  |
| Naproxen, Esomeprazole strontium | Naproxen Esomeprazole Magnesium |  | 2021-07-20 |  |  | |
| Perrigo | Naproxen | Naproxen |  | 1997-01-13 |  |  |
| Naproxen, Diphenhydramine | Naproxen Diphenhydramine |  | 2019-05-10 |  |  | |
| Pseudoephedrine, Naproxen | Naproxen Pseudoephedrine |  | 2004-03-17 |  |  | |
| P&L Developments (PLD) | Naproxen, Diphenhydramine | Naproxen Diphenhydramine |  | 2019-01-25 |  |  |
| Cipla | Naproxen | Naproxen |  | 2011-08-24 |  |  |
| Sandoz | Naproxen | Naproxen |  | 1993-12-21 |  |  |
| Bayer | Naproxen, Pseudoephedrine, Diphenhydramine | Aleve |  | 1994-01-11 |  |  |
| Takeda | Naproxen, Lansoprazole | Prevacid Naprapac |  | 2003-11-14 |  |  |
| Aurobindo Pharma | Naproxen | Naproxen |  | 2001-04-19 |  |  |
| Pseudoephedrine, Naproxen | Naproxen Pseudoephedrine |  | 2022-06-01 |  |  | |
| Naproxen, Sumatriptan | Sumatriptan Naproxen |  | 2018-02-15 |  |  |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
78%7/9
Phase 2
35%8/23
Phase 3
59%24/41
Approved: 3Overall Success rate: 16%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use